18/08/2025
MASLD has become the most common chronic liver disease worldwide. Giovanni Targher, MD, Luca Valenti, MD, and Christopher D. Byrne, MB, ChB, review the features of the disease as well as pharmacotherapies targeting the associated liver and cardiovascular–renal–metabolic issues.